Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy

Back

ESC Professional Premium Access

Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy

Session: Cardio-oncology: treatments and outcomes

Topic: Cardio-Oncology

Speaker: Doctor C. Mann (Vienna, AT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Christopher Mann

Medical University of Vienna, Vienna (Austria)

0 follower

9 more presentations in this session

The impact of peptide receptor radionucleotide therapy with Lutetium-177 DOTATATE on cardiac metastases in neuroendocrine tumors

Speaker: Associate Professor C. Ayoub (Scottsdale, US)

The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitor therapy

Speaker: Doctor M. Slieman (Tel Aviv, IL)

Long term risk of heart failure in adult cancer survivors: a systematic review and meta-analysis

Speaker: Doctor J. Wong (Melbourne, AU)

Assessment of right ventricular dysfunction in breast cancer patients undergoing anthracycline and trastuzumab treatment

Speaker: Doctor M. Santa Ana Bayona (Mexico City, MX)

Association between PCSK9 inhibitor with cause-specific morality amongst cancer survivors

Speaker: Professor T. Liu (Tianjin, CN)

Access the full session

Cardio-oncology: treatments and outcomes

Speakers: Doctor C. Mann, Associate Professor C. Ayoub, Doctor M. Slieman, Doctor J. Wong, Doctor M. Santa Ana Bayona...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources